Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally advanced therapy.
- Authors
- Denlinger, Crystal Shereen; Sym, Sun Jin; Bendell, Johanna C.; Alsina, Maria; Watkins, David; Chao, Yee; Cubillo, Antonio; Kunz, Pamela L.; Sun, Weijing; Baeksgaard, Lane; Chen, Li-Tzong; Horgan, Kerry; Frye, Saaha; Kudia, Arthur J.; McDonagh, Charlotte Fenton; Czibere, Akos Gabor; Moyo, Victor M.; Chibaudel, Benoist; Bang, Yung-Jue
- Issue Date
- 20-May-2014
- Publisher
- AMER SOC CLINICAL ONCOLOGY
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.32, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 32
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Sym, Sun Jin
- College of Medicine (Department of Medicine)